Company Filing History:
1 out of 1,209 
1 out of 1,373 
Years Active: 2023
Title: Innovator and Researcher: Andrew Lane
Introduction: Andrew Lane is an accomplished inventor based in Needham, Massachusetts. With a focus on medical research, he has made significant contributions to understanding cellular resistance to toxins, earning him recognition in the field of biomedical innovation.
Latest Patents: Andrew Lane holds a patent entitled "Methods determining and treating cellular resistance to ADP-ribosylating toxin." This invention identifies DPH1 and other members of the diphthamide synthesis pathway as biomarkers of resistance to ADP-ribosylating toxins in cells. The methods proposed aim to assess and treat conditions that exhibit resistance to these harmful agents, showcasing the intersection of toxicology and cellular biology.
Career Highlights: Lane has gained valuable experience working with esteemed institutions such as the Dana-Farber Cancer Institute and Brigham and Women's Hospital. His work in these organizations has allowed him to collaborate with leading scientists and researchers in the oncology field, fostering an environment of innovation and discovery.
Collaborations: Among his notable collaborations is his partnership with Jon C. Aster, a colleague known for his contributions to cancer research. Their joint efforts exemplify the collaborative spirit prevalent in the scientific community, where shared knowledge drives the pursuit of novel solutions in medicine.
Conclusion: Andrew Lane's innovative work and patent in identifying and treating cellular resistance to toxins highlight the essential role of inventors in advancing medical science. His contributions through research and collaboration with renowned hospitals position him as a key figure in the ongoing battle against toxins affecting human health.